CEACAM1 and neoplasm: An overlay of the scaled expression of CEACAM1 on the viSNE map (Fig. 6b) and its quantification showed significantly increased CEACAM1 levels in the treatment-resistant tumor samples relative to expression in healthy donor controls (Fig. 6c).